Skip to main content
. 2015 Aug 24;6:8022. doi: 10.1038/ncomms9022

Table 1. Association between RHBDD1 expression and clinicopathologic parameters in 539 colorectal cancer patients.

Clinicopathologic parameters N RHBDD1 expression
P value*
    Negative Positive  
Gender       0.193
 Male 327 182 145  
 Female 212 130 82  
Age       0.080
 ≤60 286 176 110  
 >60 253 136 117  
Smoking       0.313
 Yes 75 39 36  
 No 464 273 191  
Alcohol abuse       0.745
 Yes 52 29 23  
 No 487 283 204  
Family history       0.399
 Yes 57 30 27  
 No 482 282 200  
Differentiation       0.006*
 Low 98 44 54  
 Moderate 398 237 161  
 High 43 31 12  
Necrosis       0.667
 Yes 23 12 11  
 No 516 300 216  
Lymphatic vessel        
 Yes 31 13 18  
 No 508 299 209  
pTNM       0.0001*
 I 1 0 1  
 II 340 220 120  
 III 198 92 106  
pT       0.408
 T1 1 0 1  
 T2 6 2 4  
 T3 518 302 216  
 T4 14 8 6  
pN       0.0002*
 N0 341 220 121  
 N1 134 61 73  
 N2 64 31 33  

pTNM, pathological tumor-node-metastasis; pT, pathological tumor; pN, pathological node.

*The significance of RHBDD1 expression in clinicopathologic parameters was calculated by χ2 test and Fisher's exact test was used when over 25% cells had expected count <5.

Family history indicates that the immediate family member of the patient has a history of digestive system tumours.